Alnylam is leading the translation of RNA interference (RNAi) into a whole new class of innovative medicines to transform the lives of people afflicted with rare genetic, cardio-metabolic, and hepatic infectious diseases. Based on Nobel Prize-winning science, RNAi therapeutics carry the potential to transform the lives of patients who have limited or inadequate treatment options.
300 Third St
Cambridge, Massachusetts 02142
877-ALNYLAM (877-256-9526)